Completed PHASE4 INTERVENTIONAL 1-arm NCT01656200

A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2

Sponsor: Indian Institute of Science

Conditions Japanese Encephalitis Japanese Encephalitis Vaccine

Interventions Live attenuated Japanese encephalitis vaccine SA14-14-2

Updated 6 times since 2017 Last updated: Apr 11, 2019 Started: May 31, 2012 Primary completion: Oct 31, 2013 Completion: Mar 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01656200, this PHASE4 trial focuses on Japanese Encephalitis and Japanese Encephalitis Vaccine and remains completed. Sponsored by Indian Institute of Science, it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
May 2019 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — May 2019 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Indian Institute of Science
National Institute of Mental Health and Neuro Sciences, India
PATH
University of Liverpool
Wellcome Trust

Data source: Indian Institute of Science

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bangalore, India